Next Article in Journal
RanBP2/Nup358 Mediates Sumoylation of STAT1 and Antagonizes Interferon-α-Mediated Antiviral Innate Immunity
Next Article in Special Issue
Contribution of Signal Transducer and Activator of Transcription 3 (STAT3) to Bone Development and Repair
Previous Article in Journal
Nanoparticle-Mediated Hyperthermia and Cytotoxicity Mechanisms in Cancer
Previous Article in Special Issue
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Lipidomic Profile of Human Sperm Membrane Identifies a Clustering of Lipids Associated with Semen Quality and Function

1
Department of Medicine, University of Padova, 35128 Padova, Italy
2
Magnetic Resonance Center (CERM) at the Department of Chemistry “Ugo Schiff”, University of Florence, 50019 Sesto Fiorentino, Italy
3
Consorzio Interuniversitario Risonanze Magnetiche MetalloProteine (CIRMMP), 50019 Sesto Fiorentino, Italy
4
Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35129 Padova, Italy
5
Department of Clinical and Experimental Medicine, University of Catania, 95125 Catania, Italy
6
Centro HERA-Unità di Medicina della Riproduzione, Via Barriera del Bosco, 51/53, Sant’Agata li Battiati, 95030 Catania, Italy
7
Department of Medicine, Unit of Andrology and Reproductive Medicine, University of Padova, Via Giustiniani, 2, 35128 Padova, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2024, 25(1), 297; https://doi.org/10.3390/ijms25010297
Submission received: 1 December 2023 / Revised: 20 December 2023 / Accepted: 21 December 2023 / Published: 25 December 2023

Abstract

:
Reduced sperm motility and/or count are among the major causes of reduced fertility in men, and sperm membranes play an important role in the spermatogenesis and fertilization processes. However, the impact of sperm lipid composition on male fertility remains under-investigated. The aim of the present study was to perform a lipidomic analysis of human sperm membranes: we performed an untargeted analysis of membrane lipid composition in fertile (N = 33) and infertile subjects (N = 29). In parallel, we evaluated their serum lipid levels. Twenty-one lipids were identified by their mass/charge ratio and post-source decay spectra. Sulfogalactosylglycerolipid (SGG, seminolipid) was the most abundant lipid component in the membranes. In addition, we observed a significant proportion of PUFAs. Important differences have emerged between the fertile and infertile groups, leading to the identification of a lipid cluster that was associated with semen parameters. Among these, cholesterol sulfate, SGG, and PUFAs represented the most important predictors of semen quality. No association was found between the serum and sperm lipids. Dietary PUFAs and SGG have acknowledged antioxidant functions and could, therefore, represent sensitive markers of sperm quality and testicular function. Altogether, these results underline the important role of sperm membrane lipids, which act independently of serum lipids levels and may rather represent an independent marker of reproductive function.

1. Introduction

Reduced sperm motility and/or count are among the major causes of reduced fertility in men. Regarding somatic cells, sperm cells also present a cell membrane with a phospholipid bilayer, whose composition strongly varies during sperm maturation [1]. In this regard, the composition and packaging of the phospholipid bilayer is recognized to have a strong influence on its biophysical properties and, as a consequence, on cell function [2]. Despite some variations among different mammalian species, mature sperm plasma membranes are characterized by a peculiar composition, with a low content of cholesterol and a high proportion of lipids containing a fatty acid chain [3,4]. In particular, cholesterol, due to its condensed polycyclic structure, is known to reduce the conformational freedom of the phospholipid bilayer, with important consequences on the membrane fluidity, ion channels’ function, and activation of the signaling pathways [5]. Given its importance in regulating sperm function, membrane cholesterol undergoes important changes from early spermatogenesis, when de novo synthesis is massively performed due to enlargement of the male germ cell size and surface remodeling [6], until the late steps of fertilization. In this particular framework, the local high bicarbonate and albumin concentrations of the female tract are invariably associated with the lowering of the membrane cholesterol content and with further sperm membrane reorganization [7]. These changes have been demonstrated as key steps conferring forward motility to sperm cells and preparing membranes for capacitation, the acrosome reaction, and fusion with the oocyte [8,9]. Thus, if the progressive reduction of cholesterol sustains the fertility potential of mature spermatozoa, the levels of membrane cholesterol are expected to lead to the opposite effect [10,11], leading to male infertility [12].
In addition to cholesterol, a major component of sperm membranes is represented by glycolipids [13]. Glycolipids are synthesized through the addition of a glycosidic head group to ceramide [14]. The only exception to this general rule is represented by the seminolipid, or sulfogalactosylglycerolipid (SGG), a peculiar glycolipid characterized by a sulfo-galactosyl glycerol and found exclusively in the membranes of sperm cells, where it plays a well-recognized role in different stages of sperm life, from spermatogenesis to the acrosome reaction and sperm–oocyte fusion [15,16].
In addition to the aforementioned roles of SGG and cholesterol, not only in spermatogenesis but also in membrane stability, it has been observed that a higher degree of phospholipid saturation is associated with reduced semen quality, which is conversely increased by the presence of major poly-unsaturated fatty acids (PUFAs) [17]. Phospholipids are crucial for the optimal function of sperm membranes, and lipids have both a structural and functional role in cells; therefore, their relative abundance and lipid class components play an important role in defining the structure of biological membranes. There is evidence of an exchange of phospholipids between sperm and the surrounding fluid during epididymal transit [18] and changes in the lateral inhomogeneity in the membrane during capacitation [19]. This suggests that the dynamic changes in sperm membranes may play an important role in sperm motility and function [20]. Indeed, reduced sperm motility has been associated with altered serum lipid composition [21], suggesting that blood lipid composition may play a role in optimal sperm function, which is consistent with the negative impact of obesity and dysmetabolism on male fertility [22]. However, the impact of serum lipids on male fertility still remains controversial. The aim of the present study was, therefore, to perform a wide untargeted lipidomic and metabolomic analysis of human sperm membranes in fertile normozoospermic men and infertile patients, together with their serum lipid profiles, in order to investigate the association between sperm and serum lipid composition and their impact on male reproductive potential.

2. Results

The clinical and semen characteristics of the fertile subjects and infertile patients are reported in Table 1. Consistent with the homogeneous sampling of the subjects, no significant differences in terms of age or BMI were observed between the two groups. However, the infertile patients showed significantly lower sperm concentrations, viability, and progressive sperm motility than the fertile subjects, but no difference in terms of sperm morphology. From the analysis of the serum hormones, no significant differences were observed in the T, LH, FSH, or estradiol levels. Also, no significant differences were found in the total serum cholesterol, LDL, HDL, or triglycerides (Table 1).

2.1. Lipidomic Analysis

After membrane lipid extraction and lipidomic untargeted analysis by LC-MS, we were able to identify twenty-one lipids from the sperm membranes of all subjects (Table 2).
The quantitative analysis of the respective lipid AUC, standardized for the number of cells, allowed for the comparative evaluation of the relative lipid composition of the sperm membranes between the two groups (Figure 1). Sulfogalactosylglycerolipid (SGG, seminolipid) was the most abundant component in the membranes (72%) and was significantly reduced in the infertile subjects (Figure 2; p = 0.004). Cholesterol sulfate represented the second most abundant lipid in the sperm membranes (6%) and was more abundant in the sperm membranes of the infertile group (p = 0.04). In addition, we observed a significant proportion of PUFAs (63% of the remaining lipids in the membranes), such as C20:4 (arachidonic acid) and phosphatidylcholine (C22:6 16:1), representing 12% and 25% of the total PUFAs in the sperm membranes, respectively. Phosphatidic acid, phosphatidylcholine, and lysophosphatidylethanolamine were all significantly reduced in the infertile group (all p < 0.05).
In order to rule out any major effect of seminal plasma debris (immature germ cells, leukocytes), in a subsample of patients (N = 5 from the infertile group and N = 5 from the fertile group), we compared the membrane lipid composition between the Percoll-isolated sperm cells and the pelleted semen samples. No difference was observed between the two cell populations (Supplementary Figure S1, all p > 0.05). Therefore, for further analyses, we considered the data obtained from pelleted semen samples, as reported in Section 4.
Principal component analysis (PCA) was carried out for subsequent statistical analysis to determine the variation in lipids and the possible relationships between their levels and other semen or serum parameters. The PCA results are summarized in Table 3.
The twenty-one lipids were grouped into five PCs, accounting for 74% of the total variance. We then included these clusters as independent variables in a multilinear regression analysis with the following parameters: serum total cholesterol, HDL, LDL, triglycerides, sperm progressive motility, normal morphology, sperm viability, and sperm concentration. Interestingly, none of the sperm lipid clusters was associated with serum lipid markers. Conversely, one of the five clusters (including SGG, phosphatidic acid, and phosphatidylcholine C18:1 16:0) was significantly associated with increased sperm motility, viability, and concentration. A second cluster (including cholesterol sulfate, phosphatydilcholine C14:0 18:1 and C22:6 16:1) was associated with sperm progressive motility. To further characterize these associations, we performed Pearson’s correlation analyses between the components of the two aforementioned clusters and the semen or serum parameters (Figure 2). We found that SGG was positively associated with LH (r = 0.657, p < 0.001), FSH (r = 0.469, p = 0.001), the sperm concentration (r = 0.326, p = 0.010), the total sperm count (r = 0.392, p = 0.002), and motility (r = 0.495, p = 0.001), and phosphatidylcholine C22:6 16:1 was positively associated with the sperm concentration (r = 0.608, p < 0.001), sperm count (r = 0.564, p = 0.001), motility (r = 0.610, p < 0.001), and viability (r = 0.535, p = 0.011). Conversely, cholesterol sulfate was negatively associated with sperm motility (r = −0.282, p = 0.04) and sperm morphology (r = −0.317; p = 0.025). None of the sperm lipids were associated with the serum lipids (all p > 0.05).
To better characterize the association of the membrane lipids with sperm motility, we performed lipid evaluation by LC-MS in a subset of semen samples from the fertile group (N = 10) after performing the swim-up technique to obtain two distinct populations of motile and immotile sperms. Using repeated-measures ANOVA, we identified significant differences between the two fractions of the following lipids: cholesterol sulfate (p < 0.001), SGG (p = 0.03), phosphatidic acid (C18:0 20:4) (p < 0.001), phosphatidylcholine (C18:1 16:0) (p = 0.002), phosphatidylcholine (C14:0 18:1) (p = 0.046), and phosphatidylcholine (C22:6 16:1) (p = 0.009). In particular, the motile fraction of sperm was characterized by an increase in all lipids except cholesterol, which was reduced (Figure 3).

2.2. Metabolomic Analysis

To characterize the role of the sperm membrane on sperm motility and sperm count, random forest (RF) models were built using the bucket matrix of CPMG spectra by further comparing the relative importance of metabolites between the infertile patients and the fertile controls. The RF model discriminating the oligozoospermic infertile subjects and the controls showed a significant differential clustering: 74% accuracy, 64% sensitivity, 80% specificity, and 0.71 AUROC (p-value = 0.01) (Figure 4A). In contrast, the RF model discriminating controls and the asthenozoospermic patients did not provide significant results: 62% accuracy, 44% sensitivity, 68% specificity, and 0.67 AUROC (p-value > 0.05) (Figure 4B). The quantified metabolites were analyzed via univariate statistics to characterize which contributed the most and the most significantly to the differences among the groups. The levels of acetate, glycine, and sn-glycero-phosphocholine were found to be significantly higher in the seminal plasma of the oligozoospermic patients (Figure 4C). Instead, no metabolites emerged as significant in the comparison between the controls and the asthenozoospermic patients, although sn-glycero-phosphocholine appeared to be 1.4-fold higher in the latter (Figure 4D).
Acetate, glycine, sn-glycero-phosphocholine, lysine, aspartate, and glutamine were significantly correlated with the sperm concentration in the whole group (Figure 4E). Moreover, sn-glycero-phosphocholine also showed a statistically significant correlation with sperm motility. Several other correlations emerged from the analysis, but none of them reached statistical significance after FDR correction.

3. Discussion

In this study, we performed an untargeted analysis of the lipid composition of human sperm membranes in fertile and infertile subjects. This analysis allowed for the quantification of 21 lipids in 62 semen samples, the levels of which were independent of the serum lipid levels. Important differences emerged between the fertile and infertile subjects, leading to the identification of specific clusters of sperm membrane lipids that were the most significantly associated with the semen parameters. Among these, in particular, cholesterol sulfate, SGG, and PUFAs represented the most important predictors of semen quality. In regards to the lipid profile of the infertile patients, we observed an increase in the contents of saturated and monounsaturated fatty acids together with a decrease in the species containing PUFAs compared to the fertile controls. As a high degree of fatty acid unsaturation is a physiological characteristic of sperm membrane lipids and crucial for the fluidity of the membrane, these results could be explained through the correlation with sperm motility, highlighting the role of oxidative stress in its mechanisms [4]. In parallel, we observed an important increase in cholesterol sulfate in the infertile patients. Cholesterol sulfate represents about 6% of the total cholesterol both in spermatozoa and seminal plasma [23], which is in agreement with our data. It is known that sperm cells undergo an important rearrangement of membranes during epididymal transit and the capacitation process, especially by cholesterol removal, which leads to a more fluid sperm membrane, which is necessary for the acrosome reaction and penetration of the egg cell [24,25]. The progressive reduction of cholesterol in the sperm membrane is a requisite for the acquisition of the fertilization capacity of mature spermatozoa; on the other hand, high levels of membrane cholesterol are expected to have the opposite effect [12]. The regulation of membrane cholesterol during sperm maturation and fertilization is very complex and regulated by many factors [26], but Sertoli cells are recognized as the first step in cholesterol acquisition by germ cells. In vitro, it has been demonstrated that Sertoli cells are able to synthesize cholesterol from acetate [27]. However, this de novo synthesis is not a sufficient source of cholesterol to ensure spermatogenesis in vivo. Therefore, it is necessary to import cholesterol from the blood circulation [26]. Evidence from human studies indicates that male obesity and diet composition could play an important role in the deregulation of spermatogenesis, sperm maturation, or fertilizing ability, but the majority of studies have not considered the plasma lipid profile. The impact of serum lipids on male fertility indeed remains controversial; even if cholesterol is essential for male fertility [28], a recent study reported that hypercholesterolemia is not associated with sperm concentration or motility in men [29]. It has also been shown that there is no correlation between the sperm concentration and the serum total cholesterol or triglycerides in humans [21]. Our data are in agreement with these studies, confirming that the association of sperm cholesterol with spermatogenesis and sperm motility is independent of serum lipids.
Given the elevated number of lipids identified by our untargeted analysis, we performed PCA to identify the lipid clusters mostly associated with semen quality. This analysis has confirmed the important role of cholesterol and PUFAs in sperm motility and fertility potential. It is well known that the fluidity of the sperm membrane is very high due to the unusually high proportion of long-chain PUFAs and that the fluidity and flexibility of the membrane are very important for the acquisition of forward sperm motility [12,30]. Fatty acids are extensively involved in sperm development, maturation, and fertilization events [31]. Many studies have examined the relationship between dietary fatty acids and fertility [32]. In immature germ cells, the percentage of saturated and essential fatty acids is higher, whereas long-chain PUFAs are significantly lower when compared to mature spermatozoa [31]. Interestingly, spermatozoa possess a higher proportion of the most representative PUFA (C22:6 n-3) compared to red blood cells [33]. This suggests that sperm cells have active fatty acid metabolism and are desaturated during spermatogenesis or maturation [34].
Safarinejad et al. [35] compared the composition of sperm fatty acids in fertile and infertile men and found higher omega-3 fatty acids in the fertile group but higher levels and percentages of arachidonic acid in the infertile group. In our study, SGG was the most abundant lipid in sperm membranes and significantly reduced in the infertile patients. SGG is the major anionic glycolipid present only in the sperm plasma membrane of mammals. The importance of SGG for spermatogenesis, as well as for the acrosome reaction and fertilization fusion, is well known [16]. The reduction of SGG in infertile patients, after standardization for the number of cells extracted for LC/MS analysis, confirms the role of SGG as a possible marker of spermatogenesis and fertilization. This hypothesis is confirmed by its positive association with FSH and LH, and its negative correlation with sperm concentration and motility. However, even if the role of SGG in spermatogenesis is well recognized, the molecular mechanisms underlying the action of SGG in this process are still unclear. Moreover, given its role in membrane stability, the positive association with sperm progressive motility is not surprising, as confirmed by a recent study showing a reduction of SGG in asthenozoospermic men [4]. The functional role of SGG in membranes is confirmed by its presence in membrane microdomains in sperm cells. As an ordered lipid, SGG is an integral component of lipid rafts, membrane domains that are platforms of cell interaction and signaling, and like other glycolipids, its involvement in cell adhesion is through its direct affinity for a number of cell surface proteins, extracellular proteins, and extracellular matrix proteins [16]. These properties are fundamental to spermatogenesis, which is greatly dependent on the interaction between developing TGCs themselves as well as between TGCs and Sertoli cells. SGG could therefore contribute to the organization and/or stability of these functional microdomains and, therefore, modulate germ cell function during spermatogenesis or membrane stability and function in mature sperms.
Significant changes in lipid metabolism, choline metabolism, and cholesterol metabolism have been reported in the seminal plasma of infertile patients with asthenozoospermia [36]. Another study performed a metabolomic analysis of fatty acids in the seminal plasma of healthy and asthenozoospermic subjects and identified high levels of oleic and palmitic acid in the samples from infertile men [37]. To this end, we performed NMR analysis on the seminal plasma of the same subjects to characterize the metabolic differences between the infertile patients and the fertile controls.
This is a preliminary study on a limited number of subjects, and further studies on a larger sample number are needed to better define the relationship between lipid composition and sperm function. Moreover, the retention times of the identified lipids should be verified by additional analytic techniques, such as magnetic resonance methods, as the possibility of in-source decay of more complex lipids cannot be ruled out. However, to our knowledge, this is the first report about the determination of untargeted lipidomic and metabolomic analysis in the sperm of infertile and fertile subjects. Importantly, our results are representative of sperm cell populations since no major difference in lipid composition has emerged from the lipidomic comparison of selected sperm cells after isolation by density gradient. Altogether, these results underline the important role of seminal lipids, which act independently of serum lipid levels and could rather represent an independent marker of spermatogenetic and reproductive function. Dietary PUFAs and SGG, in particular, have acknowledged antioxidant functions and could, therefore, represent the most sensitive markers of sperm quality and testicular function. However, to unambiguously associate SGG levels to male infertility, studies on larger populations are needed to provide a threshold level of sperm SGG that segregates between fertile and infertile men. The multi-factorial role of SGG in male reproduction has already been proven in animals and in vitro studies on human sperm, confirming the validity of SGG levels as a marker of male fertility. Such a reliable parameter is much needed at the present time, since the current standard semen parameters have low prediction accuracy for sperm fertilizing ability and male fertility.

4. Materials and Methods

4.1. Subjects and Semen Analysis

Twenty-nine infertile patients with altered semen parameters were included in the study. The inclusion criterion was an age between 20 and 40 years. The exclusion criteria were varicocele, metabolic syndrome, malignancies, history of cryptorchidism, a history of testicular cancer, and medical treatments or dietary supplements in the 3 months preceding the study. In infertile patients, the female factor was excluded as reported previously [12]. Given the aim of the study, to achieve a representative analysis of the whole sperm population in semen and to avoid possible bias from other cell types, we selected a priori only subjects with non-sperm cells (spermatids, round cells, leukocytes) <1 million/mL. Thirty-three age-matched normozoospermic fertile subjects, who had children in the previous two years, served as controls. All patients underwent physical examination, including anthropometric measurements, such as body weight, height, waist, and hip circumference. Body mass index (BMI) was calculated as the ratio between body weight (in kg) and the square of the height (in meters). All subjects underwent semen donation by masturbation into sterile containers after 2–5 days of sexual abstinence. The samples were allowed to liquefy for 30 min and examined for sperm count, viability, motility, and morphology according to the WHO criteria (WHO, 2021). The semen parameter thresholds, which allowed for further characterization of oligozoospermia and asthenozoospermia, were based on the 5th percentiles from the WHO 6th Edition (2021). After semen evaluation, the samples were washed twice in phosphate-buffered saline (PBS). The cell number of each sperm sample was then counted with a Makler counting chamber, pelleted, and stored at −80 °C until use.

4.2. Swim-Up

The isolation of sperm cells with high progressive motility was performed by swim-up procedure, as previously described, with slight modifications [38]. As a brief description, the spermatozoa were washed twice in SWM and pelleted at 700g for 7 min. After the second centrifugation, the sperm cell pellet was covered with 0.5 mL of fresh SWM and incubated at 37 °C for another 45 min. Supernatants containing the sperm fraction with a high percentage of progressive cell motility were then carefully separated from the underlying cell suspension, and both fractions were washed and frozen and then stored at −80 °C until use.

4.3. Sperm Cell Isolation by Density Gradient

In order to isolate the sperm populations on the basis of their morphology and motility as well as their separation from leukocytes and immature germ cells, an isotonic density gradient was applied as described elsewhere [39]. To describe it briefly, isotonic 100% Percoll (Sigma Chemical Co., St Louis, MO, USA) was obtained by adding nine parts of Percoll to one part of Earle’s salt solution 10× (Imperial, UK). The 100% Percoll was diluted with Earle’s salt solution to obtain the following dilutions: 30%, 35%, 40%, 45%, 50%, 55%, 60%, 70%, 80%, and 100%. The gradient column was prepared in a 15 mL Falcon tube by gently layering 1 mL of each of the above-mentioned solutions, starting from the 100% fraction at the bottom (0.5 mL for each dilution was used when the semen volume available was 0.5 mL). One milliliter of the semen (or the whole semen in cases with less than 1 mL of ejaculate) was diluted with Earle’s solution (1:2) and centrifuged at 400 g for 15 min at 18 °C. The semen cell pellet was resuspended in 0.5 mL of Earle’s solution. The semen cell suspension was gently stratified on top of the discontinuous Percoll gradient and centrifuged for 25 min at 800 g at 18 °C. The single Percoll fractions were separated, and each was put into a single test tube. The single fractions were analyzed in order to select the ones with the greatest concentration of immature germ cells. The fractions that contained the majority of immature germ cells (30%, 35%, 40%, and 45%) were mixed with Earle’s solution (1:2) and centrifuged at 150 g for 10 min at 18 °C. The pellet was resuspended in 1 mL of Earle’s solution, and the cell concentration was evaluated.

4.4. Extraction and Quantitative Determination of Lipids by LC-MS

Analysis of the phospholipids was performed by LC-MS using the Agilent 1260 chromatograph–mass spectrometer, ion trap MS-500 (Varian, Palo Alto, CA, USA). Column Tosohas TSK gel amide 3.0 × 150 was used, and mobile phases were water 0.1% formic acid (A) and acetonitrile (B). The gradient was: min 0, 10:90 (A:B); min 20, 20:80 (A:B); min 25, 20:80 (A:B); min 45, 65:35 (A:B); min 51, 65:35 (A:B); min 52, 10:90 (A:B), and re-equilibration for 10 min. The spectra were acquired in the negative ion mode in the range of m/z 50–1000. Fragmentation of the main ionic species was obtained using the turbo data-dependent scan (tdds) function of the instrument. Tentative identification of the phospholipids was performed by comparison with the literature. For quantification of the phospholipids, phosphatidyl serine was used as a reference compound, with phosphatidyl inositol and phosphatidyl choline. The samples were prepared by extracting 1 mL of semen in dichloromethane (0.5 mL) in an Eppendorf tube and separating the organic layer. Extraction was repeated three times. The organic layers were evaporated in a vacuum in a round-bottom flask. Finally, the residue was dissolved in 200 microliters of acetonitrile and used for the analysis.

4.5. NMR Analysis

The seminal plasma samples were thawed at room temperature and shaken before use. A total of 350 µL of sodium phosphate buffer (75 mM Na2HPO4x7H2O; 20% (v/v) 2H2O, 6.1 mM NaN3; 4.6 mM 3-(Trimethylsilyl)propionate-2,2,3,3-d4; pH 7.4) was added to 350 µL of each sample. Each mixture was homogenized by vortexing for 30″, and then 600 µL was transferred into a 5 mm NMR tube. The NMR spectra were acquired at a Bruker 600 MHz spectrometer (Bruker BioSpin, Billerica, MA, USA) operating at 600.13 MHz proton Larmor frequency equipped with an automatic and refrigerated (6 °C) sample changer (SampleJet, Bruker BioSpin, Billerica, MA, USA). To ensure high spectral quality and reproducibility, the spectrometer was calibrated daily following the strict standard operating procedures. The detailed description of instrument configuration can be retrieved from our previous publication [40]. All samples were acquired at 310 K.
Seminal plasma consists of various biochemical components, such as cholesterol, lipids, proteins, and metabolites [41]. Thus, to allow for the selective detection of the signals of low-molecular-weight metabolites, a water-suppression 1D 1H CPMG experiment (cpmgpr1d; Bruker BioSpin, Billerica, MA, USA) was performed. The acquisition was performed using 32 scans, 4 dummy scans, 73,728 datapoints, a spectral window of 12,019 Hz, an acquisition time of 3.067 s, a relaxation delay of 4 s, and a total spin-echo delay of 80 ms. A line-broadening factor of 0.3 Hz was applied to each free-induction decay before the application of the Fourier transform. The transformed spectra were corrected for phase and baseline distortions with automatic routines and calibrated at the glucose-6-phosphate signal at δ 5.22 ppm using TopSpin 3.6 (Bruker BioSpin, Billerica, MA, USA).

4.6. Sex Hormone Quantification

Blood was collected in the fasting state between 08:00 and 10:00 AM. The serum total testosterone (T), follicle-stimulating hormone (FSH), estradiol (E), and luteinizing hormone (LH) were evaluated by commercial electrochemiluminescence immunoassay methods (Elecsys 2010; Roche Diagnostics, Mannheim, Germany). For all parameters, the intra- and interassay coefficients of variation were <8% and <10%, respectively. All determinations were performed in duplicate.

4.7. Biochemical Serum Markers Evaluation

The total blood cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides were measured through standard biochemical methods by commercial electrochemiluminescence immunoassay methods (Elecsys 2010; Roche Diagnostics, Basilea, Swiss) at the Central Laboratory of University Hospital, Padova.

4.8. Statistical Analysis

The results were expressed as the means ± SDs. The Shapiro–Wilk W test for normality was used to check the distributions of the variables. The Mann–Whitney test was used to assess differences among the groups in the anthropometric, seminal, and hormonal parameters and in the concentrations of the serum and seminal lipids. Adjustment for multiple comparisons was calculated with the Bonferroni–Holm method. The Spearman rank correlation coefficients were calculated to evaluate the correlations between the concentrations of sperm lipids and the variables of interest. Given the elevated number of sperm lipids and their elevated inter-correlations, in order to identify a reduced cluster of lipids associated with semen parameters, we performed principal component analysis (PCA) to reduce the data variability. This is a data-reduction technique aimed at explaining most of the variance in the data by transforming a set of correlated measured variables into a new set of uncorrelated principal components (PCs), which preserve the relationships present in the original data [42]. PCA can be easily extended to the simultaneous analysis of multiple correlated data sets. In the present study, PCA was conducted to assess the possible distribution of the different sperm membrane lipids, as well as to assess any possible correlation with seminal parameters. Correlation coefficients < 0.4 were discarded. Finally, a hierarchical cluster analysis was conducted to confirm some of the conclusions obtained by the PCA. We considered Eigenvalues > 1 as a threshold to select the final clusters, obtaining a final set of 5 clusters that explained 74% of the total variance, with a Kaiser–Meyer–Olkin value = 0.626, p < 0.001. The Varimax method with Kaiser normalization was used as a rotation method for the component matrix. For the comparison of immotile and motile sperm fractions within subjects, we performed a repeated-measures ANOVA. For metabolomic analysis, multivariate data analysis was performed on bucketed spectra. Through an R script developed in-house, equidistant bucket tables, using a 0.02 ppm bucket width, were respectively generated for CPMG and diffusion-edited spectra in the region between 0.2 and 10 ppm (excluding the region containing the residual water signal of 4.6–4.8 ppm). Then, probabilistic quotient normalization [43] was applied to the data matrices. Random forest (RF) was used as a classification algorithm to discriminate among the groups of interest. The R package ‘Random Forest’ was used to grow a forest of 1000 trees using the default settings. To reduce the potential bias due to an unbalanced number of samples per group, the function option “sampsize” was used. The accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUROC) were calculated according to the standard definitions. The AUROC was assessed for significance against the null hypothesis of no prediction accuracy in the model by means of a 102 randomized class-permutations test. In all spectra, the signals of a panel of 38 metabolites were unambiguously identified using the Chenomx Profiler (Version 9.0, evaluation license), the freely available database HMDB [44], and the published literature when available. Each signal was quantified via the peak integration of its spectral region. The non-parametric Wilcoxon rank–sum test was used to infer differences among the groups of interest. Robust correlations were calculated between the metabolomic and clinical data following the 10% Winsorized correlation approach using the function “wincor” of the R package “WRC2”. The p-values of all univariate analyses were adjusted for multiple testing using the false discovery rate (FDR) procedure with Benjamini–Hochberg correction at α = 0.05.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms25010297/s1.

Author Contributions

A.D.N., L.D.T., C.F. and A.G. contributed to the conception/design of the research and acquisition/analysis of the literature data; A.D.N., A.G., L.D.T., S.L.V., A.V., L.T. and I.S. equally contributed drafted the manuscript; A.D.N., L.T., S.D. and L.D.T. concept and performed data analyses. S.S., R.A.C., F.G., A.F. and A.G. critically revised the paper for important intellectual content. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study has been approved by the Institutional Review Board of the University Hospital of Padova (protocol n. 5782/AO/23), and each participant signed informed consent. This study was conducted in accordance with the principles expressed in the Declaration of Helsinki.

Informed Consent Statement

Informed consent was obtained from all subjects involved in this study.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author.

Acknowledgments

The authors acknowledge Andrea Bellussi for patient management; Instruct-ERIC, a Landmark ESFRI project; and specifically, the CERM/CIRMMP Italy Infrastructure. We thank Giulia De Francesco for manuscript editing. AV contributed to the present study before her full-time involvement in the project PNRR PE8 Age-It (funded under decree n. 341/2022 of the Italian Ministry of University).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Nikolopoulou, M.; Soucek, D.A.; Vary, J.C. Changes in the Lipid Content of Boar Sperm Plasma Membranes during Epididymal Maturation. Biochim. Biophys. Acta 1985, 815, 486–498. [Google Scholar] [CrossRef] [PubMed]
  2. Zerbinati, C.; Caponecchia, L.; Rago, R.; Leoncini, E.; Bottaccioli, A.G.; Ciacciarelli, M.; Pacelli, A.; Salacone, P.; Sebastianelli, A.; Pastore, A.; et al. Fatty Acids Profiling Reveals Potential Candidate Markers of Semen Quality. Andrology 2016, 4, 1094–1101. [Google Scholar] [CrossRef] [PubMed]
  3. Aitken, R.J. The Amoroso Lecture. The Human Spermatozoon—A Cell in Crisis? J. Reprod. Fertil. 1999, 115, 1–7. [Google Scholar] [CrossRef] [PubMed]
  4. Lopalco, P.; Vitale, R.; Cho, Y.S.; Totaro, P.; Corcelli, A.; Lobasso, S. Alteration of Cholesterol Sulfate/Seminolipid Ratio in Semen Lipid Profile of Men With Oligoasthenozoospermia. Front. Physiol. 2019, 10, 1344. [Google Scholar] [CrossRef] [PubMed]
  5. Ray, S.; Kassan, A.; Busija, A.R.; Rangamani, P.; Patel, H.H. The Plasma Membrane as a Capacitor for Energy and Metabolism. Am. J. Physiol. Cell Physiol. 2016, 310, C181–C192. [Google Scholar] [CrossRef] [PubMed]
  6. Potter, J.E.R.; James, M.J.; Kandutsch, A.A. Sequential Cycles of Cholesterol and Dolichol Synthesis in Mouse Spleens during Phenylhydrazine-Induced Erythropoiesis. J. Biol. Chem. 1981, 256, 2371–2376. [Google Scholar] [CrossRef] [PubMed]
  7. Yanagimachi, R. Fertility of Mammalian Spermatozoa: Its Development and Relativity. Zygote 1994, 2, 371–372. [Google Scholar] [CrossRef]
  8. Nakanishi, Y.; Shiratsuchi, A. Phagocytic Removal of Apoptotic Spermatogenic Cells by Sertoli Cells: Mechanisms and Consequences. Biol. Pharm. Bull. 2004, 27, 13–16. [Google Scholar] [CrossRef]
  9. Visconti, P.E.; Ning, X.P.; Fornés, M.W.; Alvarez, J.G.; Stein, P.; Connors, S.A.; Kopf, G.S. Cholesterol Efflux-Mediated Signal Transduction in Mammalian Sperm: Cholesterol Release Signals an Increase in Protein Tyrosine Phosphorylation during Mouse Sperm Capacitation. Dev. Biol. 1999, 214, 429–443. [Google Scholar] [CrossRef]
  10. Needham, D.; Mcintosh, T.J.; Evans, E. Thermomechanical and Transition Properties of Dimyristoylphosphatidylcholine/Cholesterol Bilayers. Biochemistry 1988, 27, 4668–4673. [Google Scholar] [CrossRef]
  11. Pelletier, R.M. The Blood-Testis Barrier: The Junctional Permeability, the Proteins and the Lipids. Prog. Histochem. Cytochem. 2011, 46, 49–127. [Google Scholar] [CrossRef] [PubMed]
  12. Garolla, A.; Šabović, I.; Tescari, S.; De Toni, L.; Menegazzo, M.; Cosci, I.; De Filippis, V.; Giarola, M.; Foresta, C. Impaired Sperm Function in Infertile Men Relies on the Membrane Sterol Pattern. Andrology 2018, 6, 325–334. [Google Scholar] [CrossRef] [PubMed]
  13. Wood, P.L.; Scoggin, K.; Ball, B.A.; Troedsson, M.H.; Squires, E.L. Lipidomics of Equine Sperm and Seminal Plasma: Identification of Amphiphilic (O-Acyl)-ω-Hydroxy-Fatty Acids. Theriogenology 2016, 86, 1212–1221. [Google Scholar] [CrossRef] [PubMed]
  14. Sandhoff, K.; Kolter, T. Biosynthesis and Degradation of Mammalian Glycosphingolipids. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2003, 358, 847–861. [Google Scholar] [CrossRef]
  15. Vos, J.P.; Lopes-Cardozo, M.; Gadella, B.M. Metabolic and Functional Aspects of Sulfogalactolipids. Biochim. Biophys. Acta 1994, 1211, 125–149. [Google Scholar] [CrossRef]
  16. Tanphaichitr, N.; Kongmanas, K.; Faull, K.F.; Whitelegge, J.; Compostella, F.; Goto-Inoue, N.; Linton, J.J.; Doyle, B.; Oko, R.; Xu, H.; et al. Properties, Metabolism and Roles of Sulfogalactosylglycerolipid in Male Reproduction. Prog. Lipid Res. 2018, 72, 18–41. [Google Scholar] [CrossRef]
  17. Macías García, B.; González Fernández, L.; Ortega Ferrusola, C.; Salazar-Sandoval, C.; Morillo Rodríguez, A.; Rodríguez Martinez, H.; Tapia, J.A.; Morcuende, D.; Peña, F.J. Membrane Lipids of the Stallion Spermatozoon in Relation to Sperm Quality and Susceptibility to Lipid Peroxidation. Reprod. Domest. Anim. 2011, 46, 141–148. [Google Scholar] [CrossRef]
  18. Frenette, G.; Girouard, J.; Sullivan, R. Comparison between Epididymosomes Collected in the Intraluminal Compartment of the Bovine Caput and Cauda Epididymidis. Biol. Reprod. 2006, 75, 885–890. [Google Scholar] [CrossRef]
  19. Kawano, N.; Yoshida, K.; Miyado, K.; Yoshida, M. Lipid Rafts: Keys to Sperm Maturation, Fertilization, and Early Embryogenesis. J. Lipids 2011, 2011, 264706. [Google Scholar] [CrossRef]
  20. Furse, S.; Kusinski, L.C.; Ray, A.; Glenn-Sansum, C.; Williams, H.E.L.; Koulman, A.; Meek, C.L. Relative Abundance of Lipid Metabolites in Spermatozoa across Three Compartments. Int. J. Mol. Sci. 2022, 23, 11655. [Google Scholar] [CrossRef]
  21. Lu, J.C.; Jing, J.; Yao, Q.; Fan, K.; Wang, G.H.; Feng, R.X.; Liang, Y.J.; Chen, L.; Ge, Y.F.; Yao, B. Relationship between Lipids Levels of Serum and Seminal Plasma and Semen Parameters in 631 Chinese Subfertile Men. PLoS ONE 2016, 11, e0146304. [Google Scholar] [CrossRef] [PubMed]
  22. Schisterman, E.F.; Mumford, S.L.; Chen, Z.; Browne, R.W.; Boyd Barr, D.; Kim, S.; Buck Louis, G.M. Lipid Concentrations and Semen Quality: The LIFE Study. Andrology 2014, 2, 408–415. [Google Scholar] [CrossRef] [PubMed]
  23. Sion, B.; Grizard, G.; Boucher, D. Quantitative Analysis of Desmosterol, Cholesterol and Cholesterol Sulfate in Semen by High-Performance Liquid Chromatography. J. Chromatogr. A 2001, 935, 259–265. [Google Scholar] [CrossRef] [PubMed]
  24. Harrison, R.A.P.; Ashworth, P.J.C.; Miller, N.G.A. Bicarbonate/CO2, an Effector of Capacitation, Induces a Rapid and Reversible Change in the Lipid Architecture of Boar Sperm Plasma Membranes. Mol. Reprod. Dev. 1996, 45, 378–391. [Google Scholar] [CrossRef]
  25. Osheroff, J.E.; Visconti, P.E.; Valenzuela, J.P.; Travis, A.J.; Alvarez, J.; Kopf, G.S. Regulation of Human Sperm Capacitation by a Cholesterol Efflux-Stimulated Signal Transduction Pathway Leading to Protein Kinase A-Mediated up-Regulation of Protein Tyrosine Phosphorylation. Mol. Hum. Reprod. 1999, 5, 1017–1026. [Google Scholar] [CrossRef] [PubMed]
  26. Sèdes, L.; Thirouard, L.; Maqdasy, S.; Garcia, M.; Caira, F.; Lobaccaro, J.M.A.; Beaudoin, C.; Volle, D.H. Cholesterol: A Gatekeeper of Male Fertility? Front. Endocrinol. 2018, 9, 369. [Google Scholar] [CrossRef]
  27. Wiebe, J.P.; Tilbe, K.S. De Novo Synthesis of Steroids (from Acetate) by Isolated Rat Sertoli Cells. Biochem. Biophys. Res. Commun. 1979, 89, 1107–1113. [Google Scholar] [CrossRef]
  28. Maqdasy, S.; Baptissart, M.; Vega, A.; Baron, S.; Lobaccaro, J.M.A.; Volle, D.H. Cholesterol and Male Fertility: What about Orphans and Adopted? Mol. Cell. Endocrinol. 2013, 368, 30–46. [Google Scholar] [CrossRef]
  29. Eisenberg, M.L.; Kim, S.; Chen, Z.; Sundaram, R.; Schisterman, E.F.; Buck Louis, G.M. The Relationship between Male BMI and Waist Circumference on Semen Quality: Data from the LIFE Study. Hum. Reprod. 2015, 30, 493–494. [Google Scholar] [CrossRef]
  30. Ladha, S. Lipid Heterogeneity and Membrane Fluidity in a Highly Polarized Cell, the Mammalian Spermatozoon. J. Membr. Biol. 1998, 165, 1–10. [Google Scholar] [CrossRef]
  31. Collodel, G.; Castellini, C.; Lee, J.C.Y.; Signorini, C. Relevance of Fatty Acids to Sperm Maturation and Quality. Oxid. Med. Cell. Longev. 2020, 2020, 7038124. [Google Scholar] [CrossRef] [PubMed]
  32. Wathes, D.C.; Abayasekara, D.R.E.; Aitken, R.J. Polyunsaturated Fatty Acids in Male and Female Reproduction. Biol. Reprod. 2007, 77, 190–201. [Google Scholar] [CrossRef] [PubMed]
  33. Lenzi, A.; Picardo, M.; Gandini, L.; Dondero, F. Lipids of the Sperm Plasma Membrane: From Polyunsaturated Fatty Acids Considered as Markers of Sperm Function to Possible Scavenger Therapy. Hum. Reprod. Update 1996, 2, 246–256. [Google Scholar] [CrossRef] [PubMed]
  34. Shan, S.; Xu, F.; Hirschfeld, M.; Brenig, B. Sperm Lipid Markers of Male Fertility in Mammals. Int. J. Mol. Sci. 2021, 22, 8767. [Google Scholar] [CrossRef] [PubMed]
  35. Safarinejad, M.R.; Hosseini, S.Y.; Dadkhah, F.; Asgari, M.A. Relationship of Omega-3 and Omega-6 Fatty Acids with Semen Characteristics, and Anti-Oxidant Status of Seminal Plasma: A Comparison between Fertile and Infertile Men. Clin. Nutr. 2010, 29, 100–105. [Google Scholar] [CrossRef] [PubMed]
  36. Zhang, X.; Diao, R.; Zhu, X.; Li, Z.; Cai, Z. Metabolic Characterization of Asthenozoospermia Using Nontargeted Seminal Plasma Metabolomics. Clin. Chim. Acta. 2015, 450, 254–261. [Google Scholar] [CrossRef]
  37. Tang, B.; Shang, X.; Qi, H.; Li, J.; Ma, B.; An, G.; Zhang, Q. Metabonomic Analysis of Fatty Acids in Seminal Plasma between Healthy and Asthenozoospermic Men Based on Gas Chromatography Mass Spectrometry. Andrologia 2017, 49, e12744. [Google Scholar] [CrossRef]
  38. Barbonetti, A.; Castellini, C.; Di Giammarco, N.; Santilli, G.; Francavilla, S.; Francavilla, F. In Vitro Exposure of Human Spermatozoa to Bisphenol A Induces Pro-Oxidative/Apoptotic Mitochondrial Dysfunction. Reprod. Toxicol. 2016, 66, 61–67. [Google Scholar] [CrossRef]
  39. Lenzi, A.; Gandini, L.; Maresca, V.; Rago, R.; Sgrò, P.; Dondero, F.; Picardo, M. Fatty Acid Composition of Spermatozoa and Immature Germ Cells. Mol. Hum. Reprod. 2000, 6, 226–231. [Google Scholar] [CrossRef]
  40. Vignoli, A.; Tenori, L.; Giusti, B.; Takis, P.G.; Valente, S.; Carrabba, N.; Balzi, D.; Barchielli, A.; Marchionni, N.; Gensini, G.F.; et al. NMR-Based Metabolomics Identifies Patients at High Risk of Death within Two Years after Acute Myocardial Infarction in the AMI-Florence II Cohort. BMC Med. 2019, 17, 3. [Google Scholar] [CrossRef]
  41. Juyena, N.S.; Stelletta, C. Seminal Plasma: An Essential Attribute to Spermatozoa. J. Androl. 2012, 33, 536–551. [Google Scholar] [CrossRef] [PubMed]
  42. Rovira, J.; Mari, M.; Nadal, M.; Schuhmacher, M.; Domingo, J.L. Levels of Metals and PCDD/Fs in the Vicinity of a Cement Plant: Assessment of Human Health Risks. J. Environ. Sci. Health-Part A Toxic/Hazard. Subst. Environ. Eng. 2011, 46, 1075–1084. [Google Scholar] [CrossRef] [PubMed]
  43. Dieterle, F.; Ross, A.; Schlotterbeck, G.; Senn, H. Probabilistic Quotient Normalization as Robust Method to Account for Dilution of Complex Biological Mixtures. Application in 1H NMR Metabonomics. Anal. Chem. 2006, 78, 4281–4290. [Google Scholar] [CrossRef] [PubMed]
  44. Wishart, D.S.; Guo, A.C.; Oler, E.; Wang, F.; Anjum, A.; Peters, H.; Dizon, R.; Sayeeda, Z.; Tian, S.; Lee, B.L.; et al. HMDB 5.0: The Human Metabolome Database for 2022. Nucleic Acids Res. 2022, 50, D622–D631. [Google Scholar] [CrossRef]
Figure 1. Comparative evaluation of the relative lipid composition measured by LC/MS as the AUC, standardized for the number of cells between the fertile (blue bars) and infertile (red bars) subjects. Sulfogalactosylglycerolipid (seminolipid) was the most abundant component in the membranes (72%). Cholesterol sulfate represented the second most abundant lipid (6%). PUFAs (63% of the remaining lipids in membranes), such as C20:4 (arachidonic acid) and phosphatidylcholine (C22:6 16:1), represented 12% and 25% of the total PUFAs in the sperm membranes, respectively. * p < 0.05.
Figure 1. Comparative evaluation of the relative lipid composition measured by LC/MS as the AUC, standardized for the number of cells between the fertile (blue bars) and infertile (red bars) subjects. Sulfogalactosylglycerolipid (seminolipid) was the most abundant component in the membranes (72%). Cholesterol sulfate represented the second most abundant lipid (6%). PUFAs (63% of the remaining lipids in membranes), such as C20:4 (arachidonic acid) and phosphatidylcholine (C22:6 16:1), represented 12% and 25% of the total PUFAs in the sperm membranes, respectively. * p < 0.05.
Ijms 25 00297 g001
Figure 2. Scatter plots of correlation analysis among sperm total count, sperm motility, and sperm viability, with the lipid components identified as the most significantly associated with semen quality by principal component analysis (PCA) from the entire group of 21 lipids. In particular, seminolipid and phosphatidylcholine (C22:6 16:1) were significantly associated with improved sperm quality, whereas cholesterol sulfate was negatively associated with motility. Lipids are reported on a logarithmic scale. p values refer to Spearman’s non-parametric correlation analysis.
Figure 2. Scatter plots of correlation analysis among sperm total count, sperm motility, and sperm viability, with the lipid components identified as the most significantly associated with semen quality by principal component analysis (PCA) from the entire group of 21 lipids. In particular, seminolipid and phosphatidylcholine (C22:6 16:1) were significantly associated with improved sperm quality, whereas cholesterol sulfate was negatively associated with motility. Lipids are reported on a logarithmic scale. p values refer to Spearman’s non-parametric correlation analysis.
Ijms 25 00297 g002
Figure 3. Within-subject analysis of 10 random semen from fertile subjects before and after selection for high-motility sperm by swim-up technique in order to identify the lipid association with sperm motility within subjects. Only lipids most significantly associated with sperm motility in the multivariate analysis were included. The AUC is reported as an exponential scale for clearer representation given the wide range of values of the different lipids analyzed.
Figure 3. Within-subject analysis of 10 random semen from fertile subjects before and after selection for high-motility sperm by swim-up technique in order to identify the lipid association with sperm motility within subjects. Only lipids most significantly associated with sperm motility in the multivariate analysis were included. The AUC is reported as an exponential scale for clearer representation given the wide range of values of the different lipids analyzed.
Ijms 25 00297 g003
Figure 4. (A) Random forest (RF) classification plot to discriminate among the groups of interest: OLIGO patients (red dots) and CTRL (light blue dots); (B) ASTHENO patients (red dots) and CTRL (light blue dots). (C) Metabolite differences in OLIGO vs. CTRL (logarithmic scale). Grey bars represent p-values < 0.05 after FDR correction. Red bars identify metabolites significantly higher (p-value < 0.05 after FDR correction). Acetate, glycine, and sn-glycero-phosphocholine were found to be significantly higher in the seminal plasma of the oligozoospermic patients with respect to CTRL. (D) Metabolite differences in ASTHENO vs. CTRL (logarithmic scale). All p-values are <0.05 after FDR correction in the comparison of ASTHENO patients vs. CTRL. No difference between groups after correction. (E) Heatmap correlations between clinical and seminal plasma metabolomic parameters (red, positive correlations; blue, negative correlation). R values are reported in the plot only for statistically significant correlations (p-value < 0.05 after FDR correction in bold, p-value < 0.05 only before FDR correction not in bold). Acetate, glycine, sn-glycero-phosphocholine, lysine, aspartate, and glutamine were significantly correlated with the sperm concentration in the whole group.
Figure 4. (A) Random forest (RF) classification plot to discriminate among the groups of interest: OLIGO patients (red dots) and CTRL (light blue dots); (B) ASTHENO patients (red dots) and CTRL (light blue dots). (C) Metabolite differences in OLIGO vs. CTRL (logarithmic scale). Grey bars represent p-values < 0.05 after FDR correction. Red bars identify metabolites significantly higher (p-value < 0.05 after FDR correction). Acetate, glycine, and sn-glycero-phosphocholine were found to be significantly higher in the seminal plasma of the oligozoospermic patients with respect to CTRL. (D) Metabolite differences in ASTHENO vs. CTRL (logarithmic scale). All p-values are <0.05 after FDR correction in the comparison of ASTHENO patients vs. CTRL. No difference between groups after correction. (E) Heatmap correlations between clinical and seminal plasma metabolomic parameters (red, positive correlations; blue, negative correlation). R values are reported in the plot only for statistically significant correlations (p-value < 0.05 after FDR correction in bold, p-value < 0.05 only before FDR correction not in bold). Acetate, glycine, sn-glycero-phosphocholine, lysine, aspartate, and glutamine were significantly correlated with the sperm concentration in the whole group.
Ijms 25 00297 g004
Table 1. Clinical and seminal characteristics of fertile subjects with normal semen parameters and infertile patients with at least one alteration in semen parameters. Significant p values in bold.
Table 1. Clinical and seminal characteristics of fertile subjects with normal semen parameters and infertile patients with at least one alteration in semen parameters. Significant p values in bold.
ParametersFertile Group (N = 33)Infertile Group (N = 29)p Value
Age (years)31.3 ± 8.332.8 ± 6.10.623
BMI (Kg/m2)23.6 ± 2.424.4 ± 3.10.422
Luteinizing hormone (IU/L)4.63 ± 1.654.52 ± 4.940.929
Follicle-stimulating hormone (IU/L)4.04 ± 1.615.37 ± 5.410.320
Estradiol (pmol/L)73.90 ± 24.1080.20 ± 34.100.189
Testosterone (nmol/L)19.79 ± 5.7918.45 ± 7.230.603
Semen volume (mL)3.14 ± 1.231.93 ± 1.03<0.001
Total sperm count (106 cells)220.06 ± 89.4226.88 ± 24.89<0.001
Sperm concentration (106 cells/mL)81.89 ± 64.4214.21 ± 10.69<0.001
Progressive motility (%)51.80 ± 17.9821.22 ± 15.32<0.001
Normal morphology (%)6.44 ± 3.315.50 ± 3.830.376
Viability (%)81.92 ± 11.9457.08 ± 24.68<0.001
Total cholesterol (mg/dL)183.48 ± 47.93192.11 ± 55.090.529
HDL (mg/dL)55.28 ± 10.0548.64 ± 11.450.612
LDL (mg/dL)108.39 ± 41.06105.22 ± 45.840.817
Triglycerides (mg/dL)102.60 ± 82.98131.14 ± 78.600.178
Table 2. List of all twenty-one lipids identified in the analysis and their respective ion molecular mass and retention time from LC-MS.
Table 2. List of all twenty-one lipids identified in the analysis and their respective ion molecular mass and retention time from LC-MS.
LipidIon Molecular Mass (Da)Main Observed FragmentRetention Time (min)
Cholesterol sulfate465Fragments8.5
Seminolipid (O-32.0)795539 3159.6
Phosphatidic acid (C18:1 18:0)701419 28313.0
Phosphatidic acid (C18:0 20:4)723419 303 28313.4
Phosphatidic acid (C18:0 22:6)747419 283 32713.5
Phosphatidic acid (C18:1 18:1)700.7463 28115.1
Phosphatidic acid (C18:1 20:4)722.8436 30313.4
Phosphatidylcholine (C14:0 18:1)716.7452 28113.8
Phosphatidylcholine (C22:6 16:1)850−60 (790) 533 480 32714.6
Phosphatidylcholine (C18:1 16:0)804−60 (744) 481 28114.8
Phosphatidylserine (C18:0 18:1)788.8(−87) 701 419 28315.0
Phosphatidylinositol (C18:0 18:1)863(−180) 683 581 42017.1
Phosphatidylinositol (C18:0 20:4)885(−161) 724 600 581 41915.4
Phosphatidylinositol (C18:1 16:0)836581 553 417 16.0
Phosphatidylinositol (C16:0 16:0)810553 41715.1
LysoPE (P-18:0/0:0) phospho-ether lipid464.9403 267 19618.6
Lysophosphatidylethanolamine (C18:0)48028317.6
Lysophosphatidylethanolamine (C18:1)47828117.6
Lysophosphatidylethanolamine (C16:0)45225518.0
Lysophosphatidylcholine (C18:0)50828320.5
Lysophosphatidylcholine (C16:0)48025519.5
Table 3. Principal component analysis (PCA) clustering.
Table 3. Principal component analysis (PCA) clustering.
MatrixLipids Included% of Explained Variance
(Cumulative Variance)
PC 1LysoPE(P-18:0/0:0) phospho-ether lipid
Lysophosphatidylethanolamine (C18:0)
Lysophosphatidylethanolamine (C18:1)
Lysophosphatidylethanolamine (C16:0)
Lysophosphatidylcholine (C16:0)
29.3%
(29.3%)
PC 2Seminolipid (O-32.0)
Phosphatidic acid (C18:0 20:4)
Phosphatidylcholine (C22:6 16:1)
Phosphatidylcholine (C18:1 16:0)
Phosphatidylinositol (C18:0 18:1)
Phosphatidylinositol (C18:0 20:4)
Phosphatidylinositol (C18:1 16:0)
Phosphatidylinositol (C16:0 16:0)
16.3%
(45.6%)
PC 3Phosphatidic acid (C18:1 18:1)
Phosphatidylcholine (C14:0 18:1)
Phosphatidylcholine (C22:6 16:1)
Phosphatidylcholine (C18:1 16:0)
Phosphatidylserine (C18:0 18:1)
Phosphatidylinositol (C18:1 16:0)
11.0%
(56.6%)
PC 4Phosphatidic acid (C18:0 20:4)
Phosphatidic acid (C18:0 22:6)
Lysophosphatidylcholine (C18:0)
8.9%
(65.5%)
PC 5Cholesterol sulfate
Phosphatidic acid (C18:1 18:0)
Phosphatidylserine (C18:0 18:1)
8.5%
(74.0%)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Di Nisio, A.; De Toni, L.; Sabovic, I.; Vignoli, A.; Tenori, L.; Dall’Acqua, S.; Sut, S.; La Vignera, S.; Condorelli, R.A.; Giacone, F.; et al. Lipidomic Profile of Human Sperm Membrane Identifies a Clustering of Lipids Associated with Semen Quality and Function. Int. J. Mol. Sci. 2024, 25, 297. https://doi.org/10.3390/ijms25010297

AMA Style

Di Nisio A, De Toni L, Sabovic I, Vignoli A, Tenori L, Dall’Acqua S, Sut S, La Vignera S, Condorelli RA, Giacone F, et al. Lipidomic Profile of Human Sperm Membrane Identifies a Clustering of Lipids Associated with Semen Quality and Function. International Journal of Molecular Sciences. 2024; 25(1):297. https://doi.org/10.3390/ijms25010297

Chicago/Turabian Style

Di Nisio, Andrea, Luca De Toni, Iva Sabovic, Alessia Vignoli, Leonardo Tenori, Stefano Dall’Acqua, Stefania Sut, Sandro La Vignera, Rosita Angela Condorelli, Filippo Giacone, and et al. 2024. "Lipidomic Profile of Human Sperm Membrane Identifies a Clustering of Lipids Associated with Semen Quality and Function" International Journal of Molecular Sciences 25, no. 1: 297. https://doi.org/10.3390/ijms25010297

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop